February 3, 2025 - 20:00

WHITE PLAINS, N.Y., February 3, 2025—In a significant leadership change, OPAL Fuels Inc. has announced the appointment of Kazi Hasan as its new Chief Financial Officer, effective immediately. Hasan steps into the role following the tenure of Scott Contino, who has been serving as the interim CFO since October 2023. Contino will maintain his position as Chief Financial Officer for Fortistar, the company’s sponsor.
Kazi Hasan brings a wealth of financial expertise and leadership experience to OPAL Fuels. His appointment is seen as a strategic move to enhance the company's financial operations and support its growth initiatives. The transition comes at a pivotal time for OPAL Fuels as it continues to expand its footprint in the renewable energy sector.
The company expressed confidence in Hasan's capabilities to drive financial strategy and operational efficiency. As OPAL Fuels embarks on its next chapter, stakeholders are optimistic about the direction under Hasan’s leadership.
March 6, 2026 - 07:28
Assessing Raymond James Financial (RJF) Valuation After Recent Share Price MomentumWith no single headline event driving attention to Raymond James Financial (RJF) today, the focus for investors is squarely on how its recent share performance and financial profile align with its...
March 5, 2026 - 22:07
Doman Building Materials Group Ltd. Reports 2025 Financial ResultsDoman Building Materials Group Ltd. has released its financial results for the full year and fourth quarter ending March 31, 2025, reporting solid revenue and profitability. For the full 2025...
March 5, 2026 - 02:47
Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial ResultsCross Country Healthcare has unveiled its financial performance for the final quarter and the entirety of the 2025 fiscal year, showcasing the company`s position in the healthcare staffing sector....
March 4, 2026 - 01:18
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 OutlookNeuroPace, Inc., a leader in developing responsive neurostimulation for epilepsy, has announced its financial results for the fourth quarter and full year ending December 31, 2025. The company also...